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It is generally assumed that male genital development is de-
termined by androgens on a default program leading to female
genitalia. Female genitalia virilization is due to high levels of
androgens, whereas feminization is linked to reduction or
lack of fetal androgen. Excess androgen determines sex re-
version in female, whereas excess estrogen does not cause
male feminization. In the present study, we investigate the
presence of androgen receptors (AR) and estrogen receptors
(ER) in human fetal penile tissue and in a cellular model of
human fetal penile smooth muscle cells (hfPSMC). By immu-
nohistochemistry, we showed the presence of ER and AR in
the developing penile tissue of male fetuses. Besides the pres-
ence of AR, hfPSMC showed ER/ as demonstrated by
RT-PCR, Western blot, and binding techniques. These re-
ceptors are functionally active because cell stimulation with
17-estradiol increased progesterone receptor B expression
and inhibited hfPSMC growth, both effects being reversed by
tamoxifen. Conversely, cell proliferation was stimulated by
R1881 and testosterone, an effect enhanced by letrozole. These
findings are the first demonstration of the presence of func-
tional ER in differentiating male external genitalia and indi-
cate a possible novel inhibitory role of estrogens in the reg-
ulation of the development of these sex structures. (J Clin
Endocrinol Metab 88: 1815–1824, 2003)
ALTHOUGH THE MOLECULAR mechanisms involvedin the development of external genitalia during fetal
life are not yet fully elucidated, this process seems to be
regulated by a complex balance between male and female sex
steroid hormones. Two phases underlie this developmental
process. The first, common to both female and male, is not
regulated by sex hormones and consists of formation and
initial outgrowth of the genital tubercle, probably under
control of the distal urethral epithelium (1, 2). During the
second phase, morphological differentiation between male
and female under the control of sex steroid hormones leads
to sexual dimorphism of the external genitalia. Developmen-
tal abnormalities in urogenital structures are one of the most
common birth defects in humans and occur in part as a
consequence of disruption of the normal equilibrium be-
tween estrogen and androgen production during the first 12
wk of fetal life (3). In the male, these defects vary from mild
to severe hypospadias, characterized by an abnormal ure-
thral opening on the ventral surface of the penis and incom-
plete formation of the scrotal folds, to various degrees of
more severe disorders of sex differentiation, known as male
pseudohermaphroditism (3). The incidence of congenital hy-
pospadias in the United States is in the range of 2–6 per 1000
live births, and, as for other male urogenital abnormalities,
the incidence of this defect has been increasing in the past few
years (4, 5). During the critical temporal window of the first
12 wk of gestation, androgens produced by the male fetus
determine the masculinization of fetal external genitalia (6).
Indeed, the start of genital differentiation corresponds to the
onset production of androgens from fetal Leydig cells (7),
and the progressive growth of penis is maintained during
pregnancy. Conversely, in the absence of androgen produc-
tion, passive development of internal and external genitalia
is thought to occur in the female fetus. Alterations in andro-
gen function and production in male fetus due to hormone
deficiency such as hypogonadotrophic hypogonadism, 5-
reductase type 2 deficiency, or androgen resistance may re-
sult in reduced development of external genitalia (8, 9). On
the other hand, females exposed during fetal life to an excess
of androgen production, often caused by 21-hydroxylase
deficiency, have normal internal but masculinized external
genitalia (10, 11) with an enlarged clitoris and fused labial
folds to an extent depending on timing and duration of
exposure (12).
Many pharmacological agents and environmental toxi-
cants can alter the normal balance between sex steroid hor-
mones, leading to a disturbance of sexual differentiation; for
this reason they have been collectively called endocrine dis-
ruptors (13, 14). Besides the role of antiandrogens in sex
reversal of male genital structures, increasing evidence
shows the detrimental effects of in utero exposure to estro-
genic compounds on reproductive organs of male fetuses
both in humans (14–18) and in experimental animals (19, 20),
suggesting a direct influence of abnormal levels of estrogens
not only on internal (21) but also on external genitalia (14).
A recent cohort study has definitely demonstrated an in-
creased risk of hypospadias in the sons of women exposed
to diethylstilbestrol (DES) in uterus (18), confirming previous
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case reports (22). Although a metaanalysis of 14 studies
showed a strict association between first trimester exposure
to sex hormones and external genitalia abnormalities only for
DES (17), many other compounds are suspected to act as
endocrine disruptors in causing urogenital abnormalities.
However, little is known about the effect of exposure to
estrogens and compounds with estrogenic activity on the
development of male external genitalia.
To understand at the molecular level the possible detri-
mental effects of environmental endocrine disruptors on the
development of male external genitalia, we investigated the
presence and activity of estrogen receptors (ER) in develop-
ing fetal penile tissue. In particular, we studied in vitro effects
on cellular growth exerted by estrogens and androgens in
established cell cultures of penile cells obtained from four
fetal penile tissues at 12 wk gestation.
Materials and Methods
Chemicals
MEM, DMEM-F12 1:1 mixture, PBS, BSA, glutamine, antibiotics, col-
lagenase type IV, trypan blue, 17-estradiol, testosterone (T), synthetic
androgen R1881, tamoxifen, the aromatase inhibitor, and reagents for
immunocytochemistry, for aromatase activity measurement, for SDS-
PAGE and peroxidase-conjugated secondary antibodies were from
Sigma Chemical Co. (St. Louis, MO). 7-3H androstenedione and
[3H]R1881 were purchased from NEN Life Science Products (Boston,
MA), whereas [2,4,6,7,16,17-3H]estradiol ([3H]estradiol) was from
Amersham Bioscences Italia (Milan, Italy). Fetal bovine serum (FBS)
was obtained by Unipath (Bedford, England). The BM enhanced-
chemiluminescence system was purchased from Roche Diagnostic
(Milan, Italy). The protein measurement kit was from Bio-Rad Labora-
tories, Inc. (Hercules, CA). Monoclonal rat antibodies against  and 
isoforms of ER (H222 and H226) used for Western blot analysis were a
kind gift from Prof. G. Greene (The Ben May Institute for Cancer Re-
search, University of Chicago, Chicago, IL). Mouse monoclonal antibody
against ER (clone ER1D5) used for immunohistochemistry was from
BioGenex Laboratories, Inc. (San Ramon, CA). Mouse monoclonal an-
tiprogesterone receptor c262 antibody was obtained from StressGen
(Victoria, Canada). Monoclonal and polyclonal antibodies to androgen
receptor (AR) were from Novocastra (Newcastle, UK) and Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). Forward and reverse primers
specific for AR, glyceraldehyde-3-phosphate dehydrogenase gene
(GAPDH), and sry were from MWG Biotech (Florence, Italy). Forward
and reverse primers specific for ER and ER were kindly supplied by
Prof. Gianna Fiorelli (Department of Clinical Physiopathology, Univer-
sity of Florence, Florence, Italy). Plasticware for cell cultures was pur-
chased from Falcon (Oxnard, CA). Disposable filtration units for growth
media preparation were purchased from PBI International (Milan, Italy).
Letrozole was a gift from Novartis Pharma (Basel, Switzerland).
Immunohistochemistry
Immunohistochemical studies were performed on deparaffinized
and rehydrated tissue sections or cultured cells fixed in 3.7% parafor-
maldehyde for 15 min, as previously described (23). The specimens were
subsequently exposed to 0.3% hydrogen peroxidase-methanol solution
to quench endogenous peroxidase activity. Slides were rinsed in tap
water, then immersed in 10 mmol/liter citrate buffer (pH 6.0), and
microwaved for 40 min at 350 W to enhance antigen exposure. The
primary antibody at the appropriate dilution in PBS was added to the
slide and incubated overnight at 4 C. Sections were rinsed in PBS,
incubated with biotinylated secondary antibodies, and finally incubated
with streptavidin-biotin peroxidase complex (LSAB kit, DAKO Corp.,
Carpinteria, CA). The reaction product was developed with deamino-
benzidine tetrahydrochloride or 3-amino-9-ethyl-carbazole as chromo-
gen. Slides were washed in running tap water and counterstained with
hematoxylin, followed by dehydration and coverslip mounting. Con-
trols were performed by processing slides lacking the primary anti-
bodies or by staining with the corresponding nonimmune serum. The
slides were evaluated and photographed with a Nikon Microphone-FX
microscope (Nikon, Tokyo, Japan).
Cell cultures
Human fetal penile smooth muscle cells (hfPSMC) were obtained
from four samples of fetal male external genitalia (11–12 wk gestation)
obtained after spontaneous or therapeutic abortion. Legal abortions
were performed in authorized hospitals, and certificates of consent were
obtained. The Local Ethical Committee gave approval for the use of
human material. Briefly, tissues were mechanically dispersed and
treated with 1 mg/ml bacterial collagenase for 15 min at 37 C. Fragments
were then collected, washed in PBS, and cultured in a 1:1 mixture
(vol/vol) of DMEM and Ham’s/F12 (DMEM/F-12 1:1 Mix) supple-
mented with 10% heat-inactivated FBS, 2 mm glutamine, 100 U/ml
penicillin, and 100 g/ml streptomycin in a fully humidified atmo-
sphere of 95% air and 5% CO2. Cells began to emerge within 24–48 h
and were used within the fifth passage. Specific antibodies were used
to characterize hfPSMC. They showed positive staining for  smooth
muscle actin, suggesting fibromuscular morphological features. Both
chromosomal analysis and PCR for sry gene confirmed that these cells
were from male fetuses. All experiments, except for immunohistochem-
istry, shown in Fig. 1, that was conducted on tissue sections from the four
fetuses, were performed on these cell cultures using positive controls as
indicated in the text.
PCR
Total RNA was extracted from hfPSMC cultures and from human
testis, corpora cavernosa, and uterus, used as positive controls, with
RNAasy Mini Kit (QIAGEN, Valencia, CA). RNA concentrations were
determined by spectrophotometric analysis at 260 nm. Total RNA (500
ng) was reverse-transcribed for 30 min at 50 C, denaturated for 2 min
at 95 C, and amplified for 30 cycles with the following parameters:
denaturation 45 sec at 95 C, annealing 1 min at 62 C for ER and 60 C for
AR, and extension 1 min at 70 C. The oligonucleotide sequences of the
pairs of specific primers used for retrotranscription and amplification
were as follows: ER sense primer (exon 1), 5-GAC CCT CCA CAC
CAA AGC ATC TG-3; ER antisense primer (exon 4), 5-CTC CTC TTC
GGT CTT TTC GTA TCC-3; ER sense primer (exon 1), 5-TAG TGG
TCC ATC GCC AGT TAT-3; ER antisense primer (exon 3, 4), 5-GGG
AGC CAC ACT TCA CCA T-3 (Ref. 23); AR sense primer, 5-ACT CTG
GGA GCC CGG AAG CTG-3; and AR antisense primer, 5-AAT GCT
TCA CTG GGT GTG GAA-3. The quality of total RNA used was
assessed by performing additional RT-PCR using primers specific for the
GAPDH gene: GAPDH sense primer, 5-CCA TGG AGA AGG CTG
GGG-3; GAPDH antisense primer, 5-CAA AGT TGT CAT GGA TGA
CC-3 (Ref. 24). The contamination of genomic DNA was excluded by
performing 35 cycles of amplification without retrotranscription.
Genomic DNA was extracted from hfPSMC by DNeasy Tissue System
according to the manufacturer’s instructions (QIAGEN). PCRs were
performed using the following primers for sry gene: sense primer, 5-
GAA TAT TCC CGC TCT CCG GA-3; antisense primer, 5-GCT GGT
GCT CCA TTC TTG AG-3. DNA was denaturated at 95 C for 5 min and
amplified for 35 cycles by the following protocol: denaturation 1 min at
95 C, annealing 1 min at 63 C, extension 1 min at 72 C.
SDS-PAGE and Western blot analysis
To evaluate the presence of AR, ER, and ER in hfPSMC, cultured
cells grown in RPMI 1640 to 70–80% confluence were washed and
scraped in PBS. After centrifugation, pellets were extracted in lysis buffer
[20 mmol/liter Tris (pH 7.4), 150 mmol/liter NaCl, 0.25% Nonidet P-40,
1 mmol/liter Na3VO4, 1 mmol/liter phenylmethylsulfonyl fluoride] on
ice for 2 h. After protein measurement, aliquots containing 30g protein
were diluted in reducing 2 Laemmli’s sample buffer [62.5 mmol/liter
Tris (pH 6.8), 10% glycerol, 2% sodium dodecyl sulfate, 2.5% pyronine,
and 100 mmol/liter dithiothreitol] and loaded onto 8% and 10% poly-
acrylamide-bisacrylamide gels. After SDS-PAGE, proteins were trans-
ferred to nitrocellulose membranes. Membranes were blocked 2 h at
room temperature in 5% milk-TTBS (0.1% Tween 20, 20 mmol/liter Tris,
150 mmol/liter NaCl) or 5% BSA-TTBS, washed in TTBS, and incubated
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FIG. 1. Immunohistochemistry for ER and AR in human fetal penile tissue. Transverse sections of human male external genitalia (MEG) of
a fetus at the 12th week of gestation. White arrows indicate the forming male urethra (UR); black arrowheads in the glans stroma (GS) indicate
the condensing connective tissue of the forthcoming CC. Note the inner prepuce (IP) surrounding the forming CC. A and B, Low magnification
of the MEG. Immunostaining for ER-positive (A) and AR-positive (B) cells was present in several portions of the MEG, including the skin (circle),
the UR, and the GS. Positivity for both sex steroid receptors occurred apparently in the same structures. C and D, Panels correspond to A and
B, respectively. Note that blood vessels (black arrows) surrounding and invading the CC are positive for ER and AR. Stromal cells of the UR
were also stained. E, ER immunostaining at the level of the prepuce showing positive endothelial and smooth muscle cells. F, Negative control
avoiding primary antibodies. Magnification, A and B, 80; C–F, 150.
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for 2 h with specific primary antibodies (rabbit anti-AR antibody 1:100
in 5% milk-TTBS or rat anti-ER antibodies 1:400 in 2% BSA-TTBS) fol-
lowed by peroxidase-conjugated secondary IgG (1:4000 either in 5%
milk-TTBS or 5% BSA-TTBS). Finally, reacted proteins were revealed by
BM enhanced-chemiluminescence system.
Binding assays
Binding assays were essentially performed as previously reported
(25). Cells grown in Ham’s/F12 (without phenol red) supplemented
with 10% stripped FBS were harvested and washed with cold TEDMo
[10 mmol/liter Tris-HCl (pH 7.4), containing 1.5 mmol/liter EDTA, 1
mmol/liter dithiothreitol, and 10 mmol/liter sodium molybdate]. Cells
were resuspended in TEDGMo (TEDMo plus 10% glycerol) and ho-
mogenized in an ultraturrax. The homogenate was appropriately di-
luted, and 100l containing 0.70 mg protein for androgen binding or 0.35
mg for estrogen binding were incubated overnight at 4 C in a final
volume of 250 l in TEDGMo with increasing concentrations of
[2,4,6,7,16,17-3H]-estradiol (specific activity, 150 Ci/mmol), in the ab-
sence (0.015, 0.03, 0.06, 0.12 nmol/liter) or presence (0.12 nmol/liter) of
increasing concentrations of nonradioactive 17-estradiol (1011 to 105
mol/liter) for estrogen binding or with increasing concentrations of
[3H]R1881 (specific activity, 68 Ci/mmol) in the absence (0.125, 0.25, 0.5,
1 nmol/liter) or presence (1 nm) of increasing concentrations of nonra-
dioactive R1881 (1010 to 106 mol/liter) for androgen binding. Dilution
of tracer was performed to optimally characterize the high-affinity
portion of the displacement curves (26). To prevent R1881 binding to
progesterone receptor (PR), 1 mol/liter triamcinolone acetonide was
added to each tube. Separation of bound and free ligand was achieved
by 15 min treatment with 500 l of a suspension of dextran-coated
charcoal (0.5% dextran, 0.5% charcoal) in 10 mmol/liter Tris-HCl (pH
7.4), 1.5 mmol/liter EDTA, 1 mmol/liter dithiothreitol at 4 C. The char-
coal was pelleted by centrifugation for 10 min at 1500  g, and 600 l
supernatant was counted in Instagel plus (Packard, Meriden, CT) in a
-counter. Protein content was determined by the method of Bradford
(26a) with BSA as standard. Data were analyzed by the computer pro-
gram LIGAND (27).
Estradiol stimulation of PR expression
PR expression in hfPSMC after 7-h stimulation with 17-estradiol and
tamoxifen was evaluated by Western blot analysis of total protein ex-
tracts separated by 8% reducing SDS-PAGE and transfer on nitrocellu-
lose membranes (28). Transferred nitrocellulose was blocked for 2 h at
room temperature in 5% BSA-TTBS, washed in TTBS, and incubated for
another 2 h with monoclonal c262 anti-PR antibody (1:400 in 2% BSA-
TTBS) followed by antimouse peroxidase-conjugated secondary IgG
(1:4000). Finally, reacted proteins were revealed by BM enhanced-chemi-
luminescence system. Quantification of bands corresponding to PR in
Western blots was made directly on the films by image scanning analysis
using Photoshop 5.5 software. Data have been reported as mean  sem
of percentage increase, with the control taken as 100%.
Cell proliferation assay
For growth measurement, 2  104 cells were seeded onto 12-well
plates in growth medium. After 24 h, the growth medium was removed,
and the cells were washed twice in PBS and then incubated in phenol
red- and serum-free medium containing 0.1% BSA. After 24 h, increasing
concentrations of 17-estradiol, T, or the synthetic androgen R1881 were
added. A fixed concentration (100 nmol/liter) of tamoxifen was simul-
taneously added to cultures stimulated with 17-estradiol, whereas a
fixed concentration (300 nmol/liter) of letrozole was added to cells
stimulated with T. Cells in phenol red- and serum-free medium con-
taining 0.1% BSA and vehicle were used as basal controls. After 24 h, cells
were trypsinized, and each experimental point was derived from he-
mocytometer counting averaging at least six different fields for each
well. In single experiments, each experimental point was repeated in
triplicate; experiments were performed at least three times.
Aromatase activity in hfPSMC culture
Aromatase activity in hfPSMC was evaluated by in-cell 3H-water
release assay (29). hfPSMC cultures at 80% confluence were added to
a solution of 1-3H androstenedione and nonradioactive steroid (to
obtain the required final concentration of 200 nmol/liter) together
with 1 mol/liter PR to inhibit 5-reductase activity. To assess the
specificity of the reaction, one dish for each experiment was incubated
in the presence of 1 mol/liter letrozole. After 48 h of incubation,
conditioned medium was collected and added to an equal volume of
dextran-coated charcoal suspension (1% charcoal, 0.5% dextran).
Samples were centrifuged at 2000 g for 15 min, and the supernatant
was extracted by shaking 30 min at room temperature with chloro-
form (1:2.5). The extracted aqueous phase was counted in a -counter.
Although proliferation experiments were performed mostly at 24-h
incubation, for evaluation of aromatase activity 48-h incubation time
was chosen to enhance the enzymatic activity and improve detection.
Statistical analysis
Statistical analysis was performed by one-way ANOVA and unpaired
or paired Student’s t tests, when appropriate, taking P values less than
0.05 as significant. The computer program ALLFIT (30) was used for the
analysis of sigmoidal dose-response curves to obtain estimates of half-
maximal inhibition (IC50) and stimulation (EC50) values. The binding
data were evaluated quantitatively with nonlinear least-squares curve
fitting using the computer program LIGAND (27). Data were expressed
as mean  sem.
Results
ER and AR are present in the developing human fetal
penile tissue
Transverse sections of the developing human male exter-
nal genitalia (12 wk gestation) are shown in Fig. 1. In these
sections, condensing connective tissue to form the corpus
cavernosum (CC) and the remodelling urethra are clearly
shown. Positivity for both ER (Fig. 1A) and AR (Fig. 1B) was
present throughout the entire developing organ, including
the skin, the urethra, and the glans stromal cells of CC.
Positivity for both sex steroid receptors occurred apparently
in the same structures, as can be appreciated at higher mag-
nification (Fig. 1C, ER; Fig. 1D, AR). Among cellular struc-
tures, numerous wide and convoluted blood vessels sur-
rounding and invading the CC appeared to be positive for ER
and AR in both endothelial and smooth muscle cells (Fig. 1C,
ER; Fig. 1D, AR). Stromal cells in the urethra were also
stained. Smooth muscle cells expressed ER as shown at high
magnification of the section at the level of the inner prepuce
(Fig. 1E). The specificity of the immunohistochemical stain-
ing was demonstrated by the absence of labeling in sections
incubated with normal serum avoiding the primary anti-
bodies (Fig. 1F).
Presence of AR and ER in hfPSMC
To investigate the presence and activity of both AR and ER
in human fetal penile tissue, we established cultures of
hfPSMC from four samples of fetal penile tissues. We first
characterized the cultured cells obtained as smooth muscle
cells by immunohistochemical positivity for  smooth mus-
cle cell antigen (data not shown). Both karyotype analysis
and PCR on genomic DNA extracted from the cells using
primers for the male specific sry gene on Y chromosome (data
not shown) confirmed the male sex of fetuses from which cell
cultures were obtained.
RT-PCR analysis of total RNA using primers designed
for the AR revealed the presence of a single cDNA band
of the expected length (893 bp) in both hfPSMC and adult
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stromal CC cells, as well as in the prostate used as positive
control (Fig. 2A). Western blot analysis of hfPSMC protein
lysates using a polyclonal antibody raised against human
AR showed a single band of about 110 kDa corresponding
to AR, as confirmed by the presence of a band migrating
at the same molecular weight in lymph node carcinoma of
prostate (LNCaP) lysates used as positive controls (Fig 2B).
AR expression in hfPSMC detected by both RT-PCR and
Western blot analysis was also confirmed by immunocy-
tochemistry on fixed cells (see Fig. 8A, inset).
Expression of both forms of ER (ER and ER) in hfPSMC
has been demonstrated by RT-PCR on total RNA extracted
from hfPSMC, testis, and uterus, used as positive controls
(Fig. 3). RT-PCR has been conducted using couples of prim-
ers in which the sense and antisense primers map on two
noncontiguous exons. This strategy avoids the possibility
that the PCR product of the expected length may be due to
genomic DNA contamination during RNA extraction, be-
cause it would generate a distinct higher PCR fragment.
Expected transcripts for ER (776 bp) and ER (418 bp) were
both expressed in hfPSMC, compared with uterus and testis
used as positive control (Fig. 3).
Western blot analysis of hfPSMC protein lysates with a
monoclonal antibody directed against the conserved ligand
binding domain of ER and ER clearly demonstrated the
presence of both a 65-kDa band corresponding to ER and
a 54-kDa band corresponding to ER compared with MCF7
cells, used as positive control (Fig. 4). ER expression in
hfPSMC detected by both RT-PCR and Western blot analysis
was also confirmed by immunocytochemistry on fixed cells
(see Fig. 7A, inset). Moreover, we found that hfPSMC not
only express both AR and ER but also specifically bind the
respective labeled androgen and estrogen ligands. In binding
studies, we found the presence of low capacity (Bmax 8.1
1.5 10 12 mol/liter for R1881 and Bmax 2.6 0.5 10
12
mol/liter for 17-estradiol) and high affinity (Kd  1.9 
0.5  1010 mol/liter for R1881 and 0.5  0.1  1010 mol/
liter for 17-estradiol) binding sites for both ligands (Fig. 5,
A for R1881, and B for 17-estradiol).
FIG. 2. AR expression in hfPSMC. A, Ethidium bromide-stained aga-
rose gels, showing RT-PCR products for AR (top) and GAPDH (bottom)
primers on total RNA from hfPSMC. Adult CC stromal cells (hCCSC)
and prostate RNA were used as positive control for AR expression. A
single band at the expected molecular weight (893 bp) was present in
hfPSMC compared with positive controls. GAPDH amplification (193
bp) was used as housekeeping gene. MWM, Molecular weight marker;
B, negative control without RNA. B, Western blot detection of AR
protein in hfPSMC. All lysates were obtained as described in Mate-
rials and Methods, and 30 g of proteins from hfPSMC and LNCaP
cells were separated by 8% SDS-PAGE, transferred onto nitrocellu-
lose membrane, and probed for AR expression with anti-AR polyclonal
antibody (1:100). A single band of about 110 kDa molecular weight
(arrowhead) was present in both hfPSMC compared with LNCaP
cells, used as positive control. Molecular weight marker (kilodaltons)
is indicated to the left of the blot.
FIG. 3. Expression of ER and ER in hfPSMC. Top,
RT-PCR for ER (upper) and ER (lower) were per-
formed on total RNA extracted from hfPSMC, human
uterus, and testis. Human uterus was used as positive
control for ER expression (left), whereas testis was used
as positive control for ER expression (right). A single
band at the expected molecular weight was found for
both ER (776 bp, upper) and ER (418, lower) in
hfPSMC compared with positive controls. Bottom,
GAPDH amplification (193 bp) was used as housekeep-
ing gene. MWM, Molecular weight marker; B, negative
control without RNA.
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Functional activity of ER in hfPSMC
To demonstrate functional activity of ER present in
hfPSMC, we evaluated the ability of 17-estradiol to regulate
PR levels, because estrogens have been widely reported to
up-regulate PR expression (31). After cell treatment with
17-estradiol (1 nmol/liter) with or without tamoxifen (100
nmol/liter), levels of PR protein were measured by Western
blot analysis of hfPSMC protein extracts using a monoclonal
antibody directed against the ligand binding domain of PR.
MCF7 lysates were used as positive control. Seven-hour
treatment with 1 nmol/liter 17-estradiol induced a clear
increase of expression of the 120-kDa PRB isoform compared
with untreated sample (Fig. 6, A and B). Conversely, the
concomitant presence of tamoxifen 100 nmol/liter signifi-
cantly reduced the stimulatory effects of estrogens (Fig. 6, A
and B). The average percentage of PRB positivity, compared
with control taken as 100%, as evaluated in five different
experiments is reported in Fig. 6B.
Effects of androgens and estrogens on hfPSMC proliferation
To investigate the possible role of ER in fetal penile tissues,
we incubated hfPSMC with increasing concentrations of 17-
estradiol (1013 to 106 mol/liter). As shown in Fig. 7A, 24-h
incubation of hfPSMC with 17-estradiol resulted in a sig-
nificant and dose-dependent decrease in cell proliferation
rate with an IC50  0.2  0.1  10
10 mol/liter. This value
is in good agreement with the affinity constant of the ER
derived from binding studies (Fig. 5B). The inhibitory effect
exerted by 17-estradiol was counteracted by the simulta-
neous treatment with tamoxifen (100 nmol/liter; Fig. 7B),
confirming the antiestrogenic effect of tamoxifen on PRB level
(Fig. 6, A and B). Conversely, androgens stimulated a time-
dependent (Fig. 8A) and dose-dependent (Fig. 8, B and C)
increase in hfPSMC proliferation. In particular, 24-h treat-
ment with increasing concentrations of the synthetic andro-
gen R1881 resulted in a significant increase in cell growth
with an EC50  4.0 0.9 10
10 mol/liter (Fig. 8B, squares).
Similarly to R1881, the aromatizable androgen T significantly
stimulated cell proliferation in a dose-dependent manner
(1010 to 107 mol/liter) with EC50  4.4  1.4  10
10
mol/liter (Fig. 8B, triangles). Mathematical analysis using the
ALLFIT program (30) of sigmoidal growth curves indicated
significant differences between maximal effects (Emax for T,
138  2; Emax for R1881, 153  2; P  0.05). At high doses
(108 and 107 mol/liter), R1881 and T stimulation of cell
growth was significantly different as evaluated by ANOVA
(Fig. 8B). However, the simultaneous incubation of the
hfPSMC cultures with the specific aromatase inhibitor letro-
zole (300 nmol/liter) completely rescued T-induced cell pro-
liferation (Fig. 8C) to the R1881 level (Fig. 8B), consistent with
the presence of endogenous aromatase activity. We therefore
evaluated aromatase activity by in-cell 3H-water release as-
say on both 48-h letrozole-treated and untreated cells. Pre-
liminary experiments showed a 123  3% increase of aro-
FIG. 4. Western blot detection of ER and ER proteins in hfPSMC.
Thirty micrograms of total proteins extracted from hfPSMC and
MCF7 cells were separated by 10% SDS-PAGE, transferred onto
nitrocellulose membrane, and probed for both ER and ER using
H226 monoclonal antibody (1:400). Two bands at the expected mo-
lecular weight (65 kDa for ER, and 55 kDa for ER) were revealed
in hfPSMC compared with the positive control, MCF7. Molecular
weight markers (kilodaltons) are indicated to the left of the blot.
FIG. 5. Binding of sex steroids to hfPSMC. A, Homologous competition curve for [3H]R1881 with unlabeled R1881 obtained pooling data from
two experiments performed in triplicate. Ordinate, Bound to total (B/T) ratio for [3H]R1881. The concentrations of the tracer were progressively
reduced to optimally characterize the high-affinity region of the curve. Abscissa, Total concentration of labeled and unlabeled R1881. B,
Homologous competition curve for [3H]estradiol with unlabeled 17-estradiol obtained pooling data from two experiments performed in
triplicate. Ordinate, B/T ratio for [3H]estradiol. The concentrations of the tracer were progressively reduced to optimally characterize the
high-affinity region of the curve. Abscissa, Total concentration of labeled and unlabeled estradiol.
1820 J Clin Endocrinol Metab, April 2003, 88(4):1815–1824 Crescioli et al. • Estrogen and Fetal Male External Genitalia
matase activity over control (100  1%), which was totally
blunted by the concomitant presence of 1 mol/liter letro-
zole (108  18%; P  0.01 vs. untreated cells at 48 h).
Discussion
The present study demonstrates for the first time the pres-
ence of functional ER in human male external genitalia. In
particular, this finding is relevant not only for understanding
the physiology of the development of human male external
genitalia, but also because it can explain the possible mech-
anism of action by which exposure to environmental toxi-
cants with estrogenic activity interferes with this process in
the male fetus. In fact, prenatal exposure to these factors has
been demonstrated to alter the normal development of fetal
sexual structures, and for these reasons these toxicants have
been classified as endocrine disruptors (14). In particular,
reduced production of androgens and exposure to molecules
acting as antiandrogens are implicated in sex reversal of male
sexual structures. However, in the last few years, the role of
FIG. 6. PR expression in hfPSMC is induced by 17-estradiol (17E2)
and inhibited by tamoxifen (Tam). A, ER functional activity was
evaluated in hfPSMC as the ability to stimulate PRB expression. PRB
protein was detected by Western blot analysis of cells stimulated for
8 h with 17-estradiol (1 nmol/liter) and Tam (100 nmol/liter) alone
or in combination. Thirty micrograms of total proteins were separated
by 10% SDS-PAGE, transferred onto nitrocellulose membrane, and
probed for PRB using c262 monoclonal antibody (1:400). A single band
at the expected molecular weight (120 kDa) was revealed in hfPSMC
compared with the positive control, MCF7 cells. Molecular weight
marker (kDa) is indicated to the left of the blot. B, Means SEM of PRB
band intensity were evaluated by image scanning in hfPSMC and
expressed as percentage of control intensity taken as 100% in the
indicated number of different experiments. *, P  0.05 vs. control; °,
P  0.005 vs. 17E2  Tam, Student’s t test for paired data. A
significant increase in PRB expression was stimulated by 17-estra-
diol, whereas Tam completely blocked 17-estradiol stimulation.
FIG. 7. Estrogens inhibit proliferation in hfPSMC. A, Twenty-four-
hour incubation with increasing concentrations of 17-estradiol
(1013 to 106 mol/liter) resulted in a statistically significant decrease
in hfPSMC proliferation rate with IC50 0.2 0.1 10
10 mol/liter.
Ordinate, Cell number expressed as percentage of the control; ab-
scissa, logarithmic scale of 17-estradiol molar concentrations. Data
were expressed as the means  SEM values obtained in six different
experiments. *, P 0.001 vs. control (0 nM), Student’s t test for paired
data. Inset, Immunocytochemistry in hfPSMC shows positivity for ER
in cell nuclei (magnification, 300). B, The inhibitory effect of 17-
estradiol on hfPSMC was counteracted by a fixed dose of the anties-
trogen tamoxifen (Tam, 100 nmol/liter). Data were expressed as the
means  SEM values obtained in three different experiments. *, P 
0.01 vs. control (0 nM); °, P  0.005 vs. Tam-treated. Student’s t test
for unpaired data.
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estrogens in determining feminization of the developing
male genital tract has been emerging, suggesting a model
called Developmental Estrogenization Syndrome as the re-
sult of disruption of embryonal programing and gonadal
development during fetal life (32), leading to the so-called
Testicular Dysgenesis Syndrome characterized by morpho-
logical and functional abnormalities in both internal and
external urogenital structures (33).
In the present study, we show the expression of ER and AR
in fetal penile tissue and cells during the first trimester of
pregnancy. These data, obtained by different experimental
techniques, including immunohistochemistry, RT-PCR,
Western blot, and binding analysis are in contrast to those of
Kallo et al. (34), who excluded ER positivity in male external
genitalia on the basis of immunohistochemistry. Because that
study (34) was conducted on fetuses older than 11–12 wk, a
decrease of ER expression with age might account for the
differences in ER positivity in male fetuses observed in the
two studies. In contrast, distribution of AR in fetal penis and
urethra, analogous to what we found, has been demonstrated
recently in humans (6). Our immunohistochemical results
clearly show that expression of both ER and AR is localized
in the same structures of the developing male external gen-
italia, suggesting putative interactions between effects ex-
FIG. 8. Androgens stimulate cell prolif-
eration in hfPSMC: effects of letrozole.
A, Time course of R1881-induced cell
growth. The stimulatory effect of 1
nmol/liter R1881 on hfPSMC prolifera-
tion was statistically significant over
different times of incubation (24, 48,
and 120 h). Data were expressed as the
means  SEM values obtained in three
different experiments. *, P  0.05 vs.
respective time points on control curve
(squares), Student’s t test for paired
data. Inset, Immunocytochemistry in
hfPSMC shows positivity for AR in cell
nuclei (magnification, 300). B, Twen-
ty-four-hour incubation with increasing
concentrations of the synthetic andro-
gen R1881 (1011 to 107 mol/liter;
squares) and T (1010 to 107 mol/liter;
triangles) resulted in an increase of
hfPSMC proliferation rate with EC50
4.0  0.9  1010 mol/liter and 4.4 
1.4  1010 mol/liter, respectively. Or-
dinate, Cell number expressed as per-
centage of the control; abscissa, loga-
rithmic scale of androgen molar
concentrations. Data were expressed as
the means SEM values obtained in five
different experiments. All points were
statistically significant vs. respective
controls (0), except for 1011 mol/liter,
Student’s t test for paired data. At high
doses (108 and 107 mol/liter), the ef-
fects between R1881 and T were statis-
tically different as evaluated by
ANOVA test. *, P  0.05. C, The simul-
taneous incubation of the hfPSMC cul-
tures with the aromatase inhibitor
letrozole (L; 300 nmol/liter) further in-
creased T-induced cell proliferation to
values comparable to the those obtained
with the same doses of R1881 (panel B).
Data were expressed as the means 
SEM values obtained in two different ex-
periments. Student’s t test for paired
data. *, P  0.05 vs. respective controls
without L.
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erted by the two steroid hormones. In particular, the posi-
tivity at the level of the forming male urethra suggests
sensitivity of this structure to both hormones, thus support-
ing a possible explanation for the occurrence of hypospadias
and related external genital defects when androgen-estrogen
balance is disrupted during male fetal development. We also
demonstrate that even ER are functionally active, because
hfPSMC bind estrogen with high affinity and low capacity.
Moreover, estrogens induce an increase in PR receptor level,
a well known transcriptional target of estrogen (31).
More importantly, we demonstrate for the first time a
direct effect of estrogen on the growth of fetal penile smooth
muscle cells in vitro. Estrogens inhibit cell proliferation in a
dose-dependent manner from 1012 mol/liter, whereas ta-
moxifen acts as an antiestrogen to reverse the estrogen effect.
In contrast, androgens such as T and the nonaromatizable
androgen R1881 stimulate cell proliferation, suggesting that
the development of male urogenital structures results from
a complex balance between estrogens and androgens. The
intracellular signaling involved in mediating estrogen effects
still has to be elucidated, although the involvement of a
cAMP-adenosine pathway in estradiol inhibition of smooth
muscle cell growth has been suggested (35). In the fetal
circulation, estrogens may be derived from different sources,
i.e. maternal, placental, and fetal tissues. However, only free
estrogens can interact with ER. Normal buffering mecha-
nisms consisting of high-affinity estrogen-binding proteins
such as circulating -fetoprotein (36) and a Leydig-specific
estrogen sulfotransferase (37, 38) control the concentration of
free estradiol in male fetus, preventing estrogens from af-
fecting fetal tissues that contain ER. However, many syn-
thetic estrogens, such as DES, are effective at lower concen-
trations than endogenous estradiol, because they do not bind
to these proteins (39). Studies on animal models defective for
these binding proteins could help us in understanding the
detrimental effects exerted by an increase in free estrogen
and estrogenic compounds on the development of male gen-
ital structures. Moreover, a maternal vegetarian diet in preg-
nancy has been demonstrated to be associated with increased
hypospadias in male sons, suggesting that phytoestrogens
present in high levels in vegetarian diet could interfere with
normal male genitalia development (40), probably through
flavonoid inhibition of estrogen binding to -fetoprotein as
demonstrated in a rat model (41). All of these findings sug-
gest that endocrine disruptors with estrogenic activity in-
terfere with normal development of external genitalia.
Recently, in the effort to elucidate the molecular mecha-
nisms underlying cellular androgen-estrogen balance, a
model based on the direct interaction between these two
steroid hormones through formation of a complex between
their activated receptors at the plasma membrane has been
proposed (42). The effects exerted by these steroids have been
called nongenomic, because they are atypically mediated by
nuclear receptors associated at plasma membrane level (43).
The present study suggests that human penile cells are not
only a target of estrogens, because they possess ER, but seem
also to be a potential fetal source of estrogens. In fact, a
specific aromatase inhibitor such as letrozole potentiates the
stimulatory effects of T on cell proliferation, increasing the
stimulated cell growth to the extent of the same doses of
the nonaromatizable androgen, R1881, suggesting that these
cells might aromatize T to estrogen.
In conclusion, this study demonstrates that ER are present
and functional in external genitalia of human male fetuses.
Moreover, estrogen inhibition of cell growth, in contrast to
the stimulatory effect of androgens, suggests that feminiza-
tion of the external male genitalia due to prenatal exposure
to abnormal levels of external estrogens may result from a
direct effect of estrogens on cell growth. In fact, although
estrogens have been demonstrated to act indirectly, reducing
fetal androgen production by limiting growth of Leydig cells
and inhibiting activity of steroidogenic enzymes involved in
T synthesis (44), this is the first time that a direct effect on
inhibition of growth of hfPSMC has been described.
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